Dr. Shigenobu Suzuki Opthalmic Oncology

Si Dr. Shigenobu Suzuki ay kabilang sa nangungunang espesyalista sa kanser sa mata sa Tokyo, Japan.

Si Dr. Shigenobu Suzuki ay nauugnay sa National Cancer Center Hospital, Japan.

The Department of Ocular Oncology is one of the rare groups specializing in ocular tumors, especially intraocular tumors. Recently, more than 70% of patients nationwide with retinoblastoma, which is the most frequent intraocular malignancy in childhood, and more than 50% of patients with choroidal melanoma, which is the most frequent primary intraocular malignancy in adults, have been referred to our department. We also treat ocular adnexal tumors. More than 350 operations have been done annually.

Nakikilahok kami sa mga klinikal na pagsubok sa pamamagitan ng pagtantya ng ocular adverse na kaganapan ng systemic chemotherapy. Ang kamakailang molecular target therapy ay minsan ay nagdudulot ng macular edema, serous retinal detachment, uveitis, ocular surface disease, at iba pa, at sinusuri at tinatrato namin ang mga salungat na kaganapang ito upang mag-ambag ng mga klinikal na pagsubok.

• Opthalmic Oncology

• Opthalmic Oncology
• retinoblastoma
• Edema ng macular
• Choroidal melanoma